TiGenix
| Use attributes for filter ! | |
| Ceo | Sebastian Wehle |
|---|---|
| Headquarters | Belgium |
| Founded | 2000 |
| Number of employees | 100 (2017 estimate) |
| Parent organizations | Takeda Pharmaceutical Company |
| Subsidiary | Coretherapix S. L. |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1165274 |
About TiGenix
TiGenix is a European cell therapy company with a proprietary validated allogeneic expanded adipose-derived stem cell platform technology for the treatment of autoimmune and inflammatory diseases, and a commercialised product. Its corporate headquarters are in Leuven, Belgium, and it has operations in Madrid, Spain.
